Shire snaps up Alba's gastrointestinal drug for $325m
US biopharma firm Alba Therapeutics has received a boost to its coffers after Shire agreed to pay up to $325m (€226m) to help bring its lead gastrointestinal drug candidate to market.
US biopharma firm Alba Therapeutics has received a boost to its coffers after Shire agreed to pay up to $325m (€226m) to help bring its lead gastrointestinal drug candidate to market.
Curiox Biosystems has developed a miniaturisation platform that enables cheaper and more efficient bioassays to be conducted, potentially slashing the costs of life science and drug discovery research.
Pronova BioPharma and FMC Corporation have signed a license and development agreement to develop products using an alginate-based capsule technology.
Patheon has finally revealed its plans to tackle the ongoing problems it has been facing with its Puerto Rican operations, which are draining the firm of profitability.